Royalty Pharma plc Quarterly Weighted Average Number of Shares Outstanding, Basic from Q2 2020 to Q4 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Royalty Pharma plc quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q2 2020 to Q4 2024.
  • Royalty Pharma plc Weighted Average Number of Shares Outstanding, Basic for the quarter ending December 31, 2024 was 448M shares, a 0.13% increase year-over-year.
  • Royalty Pharma plc annual Weighted Average Number of Shares Outstanding, Basic for 2024 was 448M shares, a 0.13% increase from 2023.
  • Royalty Pharma plc annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 448M shares, a 2.2% increase from 2022.
  • Royalty Pharma plc annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 438M shares, a 5.59% increase from 2021.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2024 448M +584K +0.13% Oct 1, 2024 Dec 31, 2024 10-K 2025-02-12
Q3 2024 448M -811K -0.18% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-06
Q2 2024 451M +615K +0.14% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 449M +3.01M +0.68% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 448M +9.64M +2.2% Oct 1, 2023 Dec 31, 2023 10-K 2025-02-12
Q3 2023 448M +9.15M +2.08% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-06
Q2 2023 450M +14.1M +3.23% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 446M +11.7M +2.69% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 438M +23.2M +5.59% Oct 1, 2022 Dec 31, 2022 10-K 2025-02-12
Q3 2022 439M +11.1M +2.58% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 436M +27M +6.59% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 434M +44.2M +11.3% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 415M Oct 1, 2021 Dec 31, 2021 10-K 2024-02-15
Q3 2021 428M +58.2M +15.7% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 409M +55.4M +15.6% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 390M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q3 2020 370M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 354M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.